Investors
Investing in the future of surgical training
Investor information for Inovus Medical: how we build affordable, high-fidelity surgical simulation, where we operate, and how to contact our investor relations team.
A global training gap
Five billion people lack access to safe surgery, and surgical training capacity is the bottleneck. Inovus Medical builds simulation that hospitals and universities can actually afford to deploy at scale.
Hardware, hydrogels and software
Our platform spans physical simulators, synthetic LAB range hydrogel tissues and the TOTUM digital surgery platform — recurring consumable and software revenue alongside capital equipment.
Evidence led
Our products are developed with practising surgeons and validated through peer-reviewed research, published in our research library and the Sunday Paper review series.
Manufacturing in the UK
Design, development and manufacture are carried out in St Helens, UK, giving us control over cost, quality and lead times as we scale into new territories.
Investor relations
For financial information, partnership discussions or shareholder queries, contact our team and mark your enquiry for investor relations. You can also read more about our people, our history and the clinical evidence behind our products.